The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Reduced Glutathione for Injection Market Research Report 2025
Synopsis
Reduced glutathione for injection is used to prevent and treat tissue cell damage caused by drugs (such as chemotherapy drugs, anti-tuberculosis drugs, psychiatric drugs, paracetamol, etc.), radiotherapy, alcohol and organophosphorus;It has a protective effect on liver damage caused by various causes.
The global Reduced Glutathione for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Reduced Glutathione for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Reduced Glutathione for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Reduced Glutathione for Injection include Biomedica Foscama, Fuan Pharmaceutical (Group) Co., Ltd., Shenyang Shuangding Pharmaceutical Co., Ltd., Beijing Sihuan Kebao Pharmaceutical Co., Ltd., Sinopharm Group Co. Ltd. and CSPC OUYI Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Reduced Glutathione for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reduced Glutathione for Injection.
Report Scope
The Reduced Glutathione for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Reduced Glutathione for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Reduced Glutathione for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biomedica Foscama
Fuan Pharmaceutical (Group) Co., Ltd.
Shenyang Shuangding Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Sinopharm Group Co. Ltd.
CSPC OUYI Pharmaceutical Co., Ltd.
Segment by Type
0.9g
1.2g
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Reduced Glutathione for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Reduced Glutathione for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Reduced glutathione for injection is used to prevent and treat tissue cell damage caused by drugs (such as chemotherapy drugs, anti-tuberculosis drugs, psychiatric drugs, paracetamol, etc.), radiotherapy, alcohol and organophosphorus;It has a protective effect on liver damage caused by various causes.
The global Reduced Glutathione for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Reduced Glutathione for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Reduced Glutathione for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Reduced Glutathione for Injection include Biomedica Foscama, Fuan Pharmaceutical (Group) Co., Ltd., Shenyang Shuangding Pharmaceutical Co., Ltd., Beijing Sihuan Kebao Pharmaceutical Co., Ltd., Sinopharm Group Co. Ltd. and CSPC OUYI Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Reduced Glutathione for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reduced Glutathione for Injection.
Report Scope
The Reduced Glutathione for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Reduced Glutathione for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Reduced Glutathione for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biomedica Foscama
Fuan Pharmaceutical (Group) Co., Ltd.
Shenyang Shuangding Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Sinopharm Group Co. Ltd.
CSPC OUYI Pharmaceutical Co., Ltd.
Segment by Type
0.9g
1.2g
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Reduced Glutathione for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Reduced Glutathione for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Reduced Glutathione for Injection Market Overview
1.1 Product Overview and Scope of Reduced Glutathione for Injection
1.2 Reduced Glutathione for Injection Segment by Type
1.2.1 Global Reduced Glutathione for Injection Market Value Comparison by Type (2024-2030)
1.2.2 0.9g
1.2.3 1.2g
1.3 Reduced Glutathione for Injection Segment by Application
1.3.1 Global Reduced Glutathione for Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Reduced Glutathione for Injection Market Size Estimates and Forecasts
1.4.1 Global Reduced Glutathione for Injection Revenue 2019-2030
1.4.2 Global Reduced Glutathione for Injection Sales 2019-2030
1.4.3 Global Reduced Glutathione for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Reduced Glutathione for Injection Market Competition by Manufacturers
2.1 Global Reduced Glutathione for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Reduced Glutathione for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Reduced Glutathione for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Reduced Glutathione for Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Reduced Glutathione for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Reduced Glutathione for Injection, Product Type & Application
2.7 Reduced Glutathione for Injection Market Competitive Situation and Trends
2.7.1 Reduced Glutathione for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Reduced Glutathione for Injection Players Market Share by Revenue
2.7.3 Global Reduced Glutathione for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Reduced Glutathione for Injection Retrospective Market Scenario by Region
3.1 Global Reduced Glutathione for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Reduced Glutathione for Injection Global Reduced Glutathione for Injection Sales by Region: 2019-2030
3.2.1 Global Reduced Glutathione for Injection Sales by Region: 2019-2024
3.2.2 Global Reduced Glutathione for Injection Sales by Region: 2025-2030
3.3 Global Reduced Glutathione for Injection Global Reduced Glutathione for Injection Revenue by Region: 2019-2030
3.3.1 Global Reduced Glutathione for Injection Revenue by Region: 2019-2024
3.3.2 Global Reduced Glutathione for Injection Revenue by Region: 2025-2030
3.4 North America Reduced Glutathione for Injection Market Facts & Figures by Country
3.4.1 North America Reduced Glutathione for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Reduced Glutathione for Injection Sales by Country (2019-2030)
3.4.3 North America Reduced Glutathione for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Reduced Glutathione for Injection Market Facts & Figures by Country
3.5.1 Europe Reduced Glutathione for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Reduced Glutathione for Injection Sales by Country (2019-2030)
3.5.3 Europe Reduced Glutathione for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Reduced Glutathione for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Reduced Glutathione for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Reduced Glutathione for Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Reduced Glutathione for Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Reduced Glutathione for Injection Market Facts & Figures by Country
3.7.1 Latin America Reduced Glutathione for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Reduced Glutathione for Injection Sales by Country (2019-2030)
3.7.3 Latin America Reduced Glutathione for Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Reduced Glutathione for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Reduced Glutathione for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Reduced Glutathione for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Reduced Glutathione for Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Reduced Glutathione for Injection Sales by Type (2019-2030)
4.1.1 Global Reduced Glutathione for Injection Sales by Type (2019-2024)
4.1.2 Global Reduced Glutathione for Injection Sales by Type (2025-2030)
4.1.3 Global Reduced Glutathione for Injection Sales Market Share by Type (2019-2030)
4.2 Global Reduced Glutathione for Injection Revenue by Type (2019-2030)
4.2.1 Global Reduced Glutathione for Injection Revenue by Type (2019-2024)
4.2.2 Global Reduced Glutathione for Injection Revenue by Type (2025-2030)
4.2.3 Global Reduced Glutathione for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Reduced Glutathione for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Reduced Glutathione for Injection Sales by Application (2019-2030)
5.1.1 Global Reduced Glutathione for Injection Sales by Application (2019-2024)
5.1.2 Global Reduced Glutathione for Injection Sales by Application (2025-2030)
5.1.3 Global Reduced Glutathione for Injection Sales Market Share by Application (2019-2030)
5.2 Global Reduced Glutathione for Injection Revenue by Application (2019-2030)
5.2.1 Global Reduced Glutathione for Injection Revenue by Application (2019-2024)
5.2.2 Global Reduced Glutathione for Injection Revenue by Application (2025-2030)
5.2.3 Global Reduced Glutathione for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Reduced Glutathione for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biomedica Foscama
6.1.1 Biomedica Foscama Corporation Information
6.1.2 Biomedica Foscama Description and Business Overview
6.1.3 Biomedica Foscama Reduced Glutathione for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biomedica Foscama Reduced Glutathione for Injection Product Portfolio
6.1.5 Biomedica Foscama Recent Developments/Updates
6.2 Fuan Pharmaceutical (Group) Co., Ltd.
6.2.1 Fuan Pharmaceutical (Group) Co., Ltd. Corporation Information
6.2.2 Fuan Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.2.3 Fuan Pharmaceutical (Group) Co., Ltd. Reduced Glutathione for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fuan Pharmaceutical (Group) Co., Ltd. Reduced Glutathione for Injection Product Portfolio
6.2.5 Fuan Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.3 Shenyang Shuangding Pharmaceutical Co., Ltd.
6.3.1 Shenyang Shuangding Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Shenyang Shuangding Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Shenyang Shuangding Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shenyang Shuangding Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product Portfolio
6.3.5 Shenyang Shuangding Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
6.4.1 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Corporation Information
6.4.2 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product Portfolio
6.4.5 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Sinopharm Group Co. Ltd.
6.5.1 Sinopharm Group Co. Ltd. Corporation Information
6.5.2 Sinopharm Group Co. Ltd. Description and Business Overview
6.5.3 Sinopharm Group Co. Ltd. Reduced Glutathione for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sinopharm Group Co. Ltd. Reduced Glutathione for Injection Product Portfolio
6.5.5 Sinopharm Group Co. Ltd. Recent Developments/Updates
6.6 CSPC OUYI Pharmaceutical Co., Ltd.
6.6.1 CSPC OUYI Pharmaceutical Co., Ltd. Corporation Information
6.6.2 CSPC OUYI Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 CSPC OUYI Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CSPC OUYI Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product Portfolio
6.6.5 CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Reduced Glutathione for Injection Industry Chain Analysis
7.2 Reduced Glutathione for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Reduced Glutathione for Injection Production Mode & Process
7.4 Reduced Glutathione for Injection Sales and Marketing
7.4.1 Reduced Glutathione for Injection Sales Channels
7.4.2 Reduced Glutathione for Injection Distributors
7.5 Reduced Glutathione for Injection Customers
8 Reduced Glutathione for Injection Market Dynamics
8.1 Reduced Glutathione for Injection Industry Trends
8.2 Reduced Glutathione for Injection Market Drivers
8.3 Reduced Glutathione for Injection Market Challenges
8.4 Reduced Glutathione for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Reduced Glutathione for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Reduced Glutathione for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Reduced Glutathione for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Reduced Glutathione for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Reduced Glutathione for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Reduced Glutathione for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Reduced Glutathione for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Reduced Glutathione for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Reduced Glutathione for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Reduced Glutathione for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Reduced Glutathione for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Reduced Glutathione for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Reduced Glutathione for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reduced Glutathione for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Reduced Glutathione for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Reduced Glutathione for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Reduced Glutathione for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Reduced Glutathione for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Reduced Glutathione for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Reduced Glutathione for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Reduced Glutathione for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Reduced Glutathione for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Reduced Glutathione for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Reduced Glutathione for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Reduced Glutathione for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Reduced Glutathione for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Reduced Glutathione for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Reduced Glutathione for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Reduced Glutathione for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Reduced Glutathione for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Reduced Glutathione for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Reduced Glutathione for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Reduced Glutathione for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Reduced Glutathione for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Reduced Glutathione for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Reduced Glutathione for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Reduced Glutathione for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Reduced Glutathione for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Reduced Glutathione for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Reduced Glutathione for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Reduced Glutathione for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Reduced Glutathione for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Reduced Glutathione for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Reduced Glutathione for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Reduced Glutathione for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Reduced Glutathione for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Reduced Glutathione for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Reduced Glutathione for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Reduced Glutathione for Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Reduced Glutathione for Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Reduced Glutathione for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Reduced Glutathione for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Reduced Glutathione for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Reduced Glutathione for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Reduced Glutathione for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Reduced Glutathione for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Reduced Glutathione for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Reduced Glutathione for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Reduced Glutathione for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Reduced Glutathione for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Reduced Glutathione for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Reduced Glutathione for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Reduced Glutathione for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Reduced Glutathione for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Reduced Glutathione for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Reduced Glutathione for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Reduced Glutathione for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Reduced Glutathione for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Biomedica Foscama Corporation Information
Table 71. Biomedica Foscama Description and Business Overview
Table 72. Biomedica Foscama Reduced Glutathione for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Biomedica Foscama Reduced Glutathione for Injection Product
Table 74. Biomedica Foscama Recent Developments/Updates
Table 75. Fuan Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 76. Fuan Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 77. Fuan Pharmaceutical (Group) Co., Ltd. Reduced Glutathione for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Fuan Pharmaceutical (Group) Co., Ltd. Reduced Glutathione for Injection Product
Table 79. Fuan Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 80. Shenyang Shuangding Pharmaceutical Co., Ltd. Corporation Information
Table 81. Shenyang Shuangding Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Shenyang Shuangding Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Shenyang Shuangding Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product
Table 84. Shenyang Shuangding Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Corporation Information
Table 86. Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product
Table 89. Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Sinopharm Group Co. Ltd. Corporation Information
Table 91. Sinopharm Group Co. Ltd. Description and Business Overview
Table 92. Sinopharm Group Co. Ltd. Reduced Glutathione for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sinopharm Group Co. Ltd. Reduced Glutathione for Injection Product
Table 94. Sinopharm Group Co. Ltd. Recent Developments/Updates
Table 95. CSPC OUYI Pharmaceutical Co., Ltd. Corporation Information
Table 96. CSPC OUYI Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. CSPC OUYI Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. CSPC OUYI Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product
Table 99. CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Reduced Glutathione for Injection Distributors List
Table 103. Reduced Glutathione for Injection Customers List
Table 104. Reduced Glutathione for Injection Market Trends
Table 105. Reduced Glutathione for Injection Market Drivers
Table 106. Reduced Glutathione for Injection Market Challenges
Table 107. Reduced Glutathione for Injection Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Reduced Glutathione for Injection
Figure 2. Global Reduced Glutathione for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Reduced Glutathione for Injection Market Share by Type in 2023 & 2030
Figure 4. 0.9g Product Picture
Figure 5. 1.2g Product Picture
Figure 6. Global Reduced Glutathione for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Reduced Glutathione for Injection Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Reduced Glutathione for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Reduced Glutathione for Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Reduced Glutathione for Injection Sales (2019-2030) & (K Units)
Figure 14. Global Reduced Glutathione for Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Reduced Glutathione for Injection Report Years Considered
Figure 16. Reduced Glutathione for Injection Sales Share by Manufacturers in 2023
Figure 17. Global Reduced Glutathione for Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Reduced Glutathione for Injection Players: Market Share by Revenue in 2023
Figure 19. Reduced Glutathione for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Reduced Glutathione for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Reduced Glutathione for Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Reduced Glutathione for Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Reduced Glutathione for Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Reduced Glutathione for Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Reduced Glutathione for Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Reduced Glutathione for Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Reduced Glutathione for Injection Sales Market Share by Country (2019-2030)
Figure 42. Latin America Reduced Glutathione for Injection Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Reduced Glutathione for Injection Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Reduced Glutathione for Injection Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Reduced Glutathione for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Reduced Glutathione for Injection by Type (2019-2030)
Figure 53. Global Revenue Market Share of Reduced Glutathione for Injection by Type (2019-2030)
Figure 54. Global Reduced Glutathione for Injection Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Reduced Glutathione for Injection by Application (2019-2030)
Figure 56. Global Revenue Market Share of Reduced Glutathione for Injection by Application (2019-2030)
Figure 57. Global Reduced Glutathione for Injection Price (US$/Unit) by Application (2019-2030)
Figure 58. Reduced Glutathione for Injection Value Chain
Figure 59. Reduced Glutathione for Injection Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
